Published in J Clin Oncol on August 01, 1999
A randomized trial of bevacizumab, an anti-vascular endothelial growth factor antibody, for metastatic renal cancer. N Engl J Med (2003) 14.59
Effect of antivascular endothelial growth factor treatment on the intratumoral uptake of CPT-11. Br J Cancer (2003) 2.40
An orally delivered small-molecule formulation with antiangiogenic and anticancer activity. Nat Biotechnol (2008) 1.19
Angiogenesis inhibitors in clinical development; where are we now and where are we going? Br J Cancer (2004) 1.15
Angiogenesis in hepatocellular carcinoma: the retrospectives and perspectives. J Cancer Res Clin Oncol (2004) 1.12
A single amino acid residue defines the difference in ovalicin sensitivity between type I and II methionine aminopeptidases. J Biol Chem (2003) 0.93
Inhibition of angiogenesis: treatment options for patients with metastatic prostate cancer. Invest New Drugs (2002) 0.92
Targeting vasculature in urologic tumors: mechanistic and therapeutic significance. J Cell Biochem (2008) 0.89
Antiangiogenic therapy for human pancreatic carcinoma xenografts in nude mice. World J Gastroenterol (2005) 0.89
The role of angiogenesis in prostate and other urologic cancers: a review. CMAJ (2001) 0.88
Structure of the angiogenesis inhibitor ovalicin bound to its noncognate target, human Type 1 methionine aminopeptidase. Protein Sci (2006) 0.88
Novel technologies for antiangiogenic drug delivery in the brain. Cell Adh Migr (2009) 0.86
From antiangiogenesis to hypoxia: current research and future directions. Cancer Manag Res (2010) 0.84
The potential of nanomedicine therapies to treat neovascular disease in the retina. J Angiogenes Res (2010) 0.84
A phase II trial of weekly intravenous ranpirnase (Onconase), a novel ribonuclease in patients with metastatic kidney cancer. Invest New Drugs (2001) 0.81
Phase II trial of the antiangiogenic agent IM862 in metastatic renal cell carcinoma. Br J Cancer (2004) 0.81
Perfusion computed tomography in renal cell carcinoma. World J Radiol (2015) 0.78
Current status and perspective of antiangiogenic therapy for cancer: urinary cancer. Int J Clin Oncol (2006) 0.77
TNP-470 Suppresses the Tumorigenicity of HT1080 Fibrosarcoma Tumor Through the Inhibition of VEGF Secretion From the Tumor Cells. Sarcoma (2001) 0.77
Common therapeutic target for both cancer and obesity. World J Biol Chem (2017) 0.75
TNP-470 fails to block the onset of angiogenesis and early tumor establishment in an intravital minimal disease model. Int J Colorectal Dis (2005) 0.75
Phase II study of interferon-alpha and doxycycline for advanced renal cell carcinoma. Invest New Drugs (2006) 0.75
The Gene Ontology (GO) database and informatics resource. Nucleic Acids Res (2004) 54.37
Food-related illness and death in the United States. Emerg Infect Dis (1999) 39.22
Alpha emitter radium-223 and survival in metastatic prostate cancer. N Engl J Med (2013) 13.90
THE STANDARDIZATION OF ANTIPNEUMOCOCCIC SERUM TYPES I AND II. J Exp Med (1930) 5.18
Duplication of the fusion of TMPRSS2 to ERG sequences identifies fatal human prostate cancer. Oncogene (2007) 4.81
Interactive memory systems in the human brain. Nature (2001) 4.53
A mathematical evaluation of the core conductor model. Biophys J (1966) 4.41
Mutations in Kir2.1 cause the developmental and episodic electrical phenotypes of Andersen's syndrome. Cell (2001) 4.25
Hydrocortisone with or without mitoxantrone in men with hormone-refractory prostate cancer: results of the cancer and leukemia group B 9182 study. J Clin Oncol (1999) 4.12
Health-related quality of life in patients served by the Department of Veterans Affairs: results from the Veterans Health Study. Arch Intern Med (1998) 4.07
Recovering meaning: left prefrontal cortex guides controlled semantic retrieval. Neuron (2001) 3.92
Impact of cancer-related fatigue on the lives of patients: new findings from the Fatigue Coalition. Oncologist (2000) 3.62
Campylobacter pyloridis in peptic ulcer disease: microbiology, pathology, and scanning electron microscopy. Gut (1985) 3.48
Relation between literacy, race, and stage of presentation among low-income patients with prostate cancer. J Clin Oncol (1998) 3.38
Prevalence of insomnia symptoms in patients with sleep-disordered breathing. Chest (2001) 3.37
The amino-terminal domain of heat shock protein 90 (hsp90) that binds geldanamycin is an ATP/ADP switch domain that regulates hsp90 conformation. J Biol Chem (1997) 3.16
A prospective, randomized, double-blind comparison of bilateral and right unilateral electroconvulsive therapy at different stimulus intensities. Arch Gen Psychiatry (2000) 3.06
Role of apoptosis in failure of beta-cell mass compensation for insulin resistance and beta-cell defects in the male Zucker diabetic fatty rat. Diabetes (1998) 2.94
Functional analysis of human T cell subsets defined by monoclonal antibodies. I. Collaborative T-T interactions in the immunoregulation of B cell differentiation. J Immunol (1980) 2.93
Interactions of mast cell tryptase with thrombin receptors and PAR-2. J Biol Chem (1997) 2.79
Control of organ asymmetry in flowers of Antirrhinum. Cell (1999) 2.74
High STOP-Bang score indicates a high probability of obstructive sleep apnoea. Br J Anaesth (2012) 2.71
Induction of immune responses in vivo with small numbers of veiled (dendritic) cells. Proc Natl Acad Sci U S A (1983) 2.68
Effects of single-dose interleukin-12 exposure on interleukin-12-associated toxicity and interferon-gamma production. Blood (1997) 2.66
A successful system of scientific data audits for clinical trials. A report from the Cancer and Leukemia Group B. JAMA (1993) 2.60
The risk of tuberculosis related to tumour necrosis factor antagonist therapies: a TBNET consensus statement. Eur Respir J (2010) 2.56
Fulminant hepatic failure: summary of a workshop. Hepatology (1995) 2.53
The t(X;1)(p11.2;q21.2) translocation in papillary renal cell carcinoma fuses a novel gene PRCC to the TFE3 transcription factor gene. Hum Mol Genet (1996) 2.45
Molecular characterisation of ERG, ETV1 and PTEN gene loci identifies patients at low and high risk of death from prostate cancer. Br J Cancer (2010) 2.45
Lead and hyperactivity. Lancet (1972) 2.42
Human midbrain sensitivity to cognitive feedback and uncertainty during classification learning. J Neurophysiol (2004) 2.41
Health status in VA patients: results from the Veterans Health Study. Am J Med Qual (1999) 2.35
The amino terminus of ADP-ribosylation factor (ARF) is a critical determinant of ARF activities and is a potent and specific inhibitor of protein transport. J Biol Chem (1992) 2.31
The extracellular potential field of the single active nerve fiber in a volume conductor. Biophys J (1968) 2.31
Clinical features, aetiology and outcome of empyema in children in the north east of England. Thorax (2004) 2.31
Mid-Pleistocene Acheulean-like stone technology of the Bose basin, South China. Science (2000) 2.28
Pivotal phase III trial of two dose levels of denileukin diftitox for the treatment of cutaneous T-cell lymphoma. J Clin Oncol (2001) 2.24
Early and delayed shut-off of host protein synthesis in cells infected with herpes simplex virus. J Gen Virol (1982) 2.22
Factors predictive of survival among 337 patients with mesothelioma treated between 1984 and 1994 by the Cancer and Leukemia Group B. Chest (1998) 2.18
Mortality among injecting drug users: a critical reappraisal. J Epidemiol Community Health (1993) 2.17
MRI findings in Susac's syndrome. Neurology (2003) 2.17
Factors impairing daytime performance in patients with sleep apnea/hypopnea syndrome. Arch Intern Med (1992) 2.15
Fusion of SYT to two genes, SSX1 and SSX2, encoding proteins with homology to the Kruppel-associated box in human synovial sarcoma. EMBO J (1995) 2.14
Independent prognostic factors in patients with metastatic (stage D2) prostate cancer. The Zoladex Study Group. JAMA (1991) 2.12
Expression of a dominant allele of human ARF1 inhibits membrane traffic in vivo. J Cell Biol (1994) 2.11
Impact of delay in diagnosis on clinical stage of testicular cancer. Lancet (1981) 2.06
Nursing: an intellectual activity. BMJ (1991) 2.03
Why nursing education has to change. Br Med J (Clin Res Ed) (1986) 2.01
Second-line hormonal therapy for advanced prostate cancer: a shifting paradigm. J Clin Oncol (1997) 1.99
Predictors of patient response to antibiotic therapy for the chronic prostatitis/chronic pelvic pain syndrome: a prospective multicenter clinical trial. J Urol (2001) 1.96
Phase I clinical and pharmacological study of O6-benzylguanine followed by carmustine in patients with advanced cancer. Clin Cancer Res (2000) 1.93
From synapse to vesicle: the reuptake and storage of biogenic amine neurotransmitters. Biochim Biophys Acta (1993) 1.89
Human ADP-ribosylation factors. A functionally conserved family of GTP-binding proteins. J Biol Chem (1991) 1.89
Benign melanocytic naevi as a risk factor for malignant melanoma. Br Med J (Clin Res Ed) (1986) 1.88
Prevalence of prostatitis-like symptoms in a population based study using the National Institutes of Health chronic prostatitis symptom index. J Urol (2001) 1.82
Phase II study of docetaxel, estramustine, and low-dose hydrocortisone in men with hormone-refractory prostate cancer: a final report of CALGB 9780. Cancer and Leukemia Group B. J Clin Oncol (2001) 1.81
Validation of a western immunoblotting procedure for bovine PrP(Sc) detection and its use as a rapid surveillance method for the diagnosis of bovine spongiform encephalopathy (BSE). Acta Neuropathol (1999) 1.76
Home antibiotic therapy for low-risk cancer patients with fever and neutropenia: a pilot study of 30 patients based on a validated prediction rule. J Clin Oncol (1994) 1.75
Prognostic significance of plasma vascular endothelial growth factor levels in patients with hormone-refractory prostate cancer treated on Cancer and Leukemia Group B 9480. Clin Cancer Res (2001) 1.72
Vascular endothelial growth factor and basic fibroblast growth factor urine levels as predictors of outcome in hormone-refractory prostate cancer patients: a cancer and leukemia group B study. Cancer Res (2001) 1.71
Human T-cell leukaemia/lymphoma virus-associated lymphoreticular neoplasia in Jamaica. Lancet (1983) 1.69
Nephrotic syndrome associated with Kimura disease. Pediatr Nephrol (2000) 1.63
Clinical assessment of the probability of coronary artery disease: judgmental bias from personal knowledge. Med Decis Making (1992) 1.63
Defects in pulmonary vasculature and perinatal lung hemorrhage in mice heterozygous null for the Forkhead Box f1 transcription factor. Dev Biol (2001) 1.59
Laparoscopic vs open appendectomy. Prospective randomized study of outcomes. Arch Surg (1997) 1.57
Comparing preincisional with postincisional bupivacaine infiltration in the management of postoperative pain. Arch Surg (1997) 1.57
Mutation of the p53 gene in human soft tissue sarcomas: association with abnormalities of the RB1 gene. Oncogene (1990) 1.56
Integrated record keeping as an essential aspect of a primary care led health service. BMJ (1998) 1.55
Radiation-resistant and repair-proficient human tumor cells may be associated with radiotherapy failure in head- and neck-cancer patients. Proc Natl Acad Sci U S A (1986) 1.51
Phase II study of single-agent gemcitabine in previously untreated patients with metastatic urothelial cancer. J Clin Oncol (1997) 1.49
Raynaud's phenomenon: a common toxicity after combination chemotherapy for testicular cancer. Ann Intern Med (1981) 1.47
Vasodilator pre-treatment of human radial arteries; comparison of effects of phenoxybenzamine vs papaverine on norepinephrine-induced contraction in vitro. Eur Heart J (2001) 1.47
The British National Health Service 1948-1978: should we start again? J Adv Nurs (1979) 1.47
Expression analysis onto microarrays of randomly selected cDNA clones highlights HOXB13 as a marker of human prostate cancer. Br J Cancer (2005) 1.46
The potential role of custody facilities in controlling sexually transmitted diseases. Am J Public Health (1992) 1.44
A phase II study of continuous infusion 5-fluorouracil in advanced hormone refractory prostate cancer. An Illinois Cancer Center Study. Cancer (1993) 1.44
Children's religious knowledge: implications for understanding satanic ritual abuse allegations. Child Abuse Negl (1997) 1.44
Behavioral versus behavioral and pharmacological treatment in ADHD children attending a summer treatment program. J Abnorm Child Psychol (2000) 1.43
Delayed radiation injury to the retrobulbar optic nerves and chiasm. Clinical syndrome and treatment with hyperbaric oxygen and corticosteroids. Ophthalmology (1990) 1.42
An upper limit on the stochastic gravitational-wave background of cosmological origin. Nature (2009) 1.42
A phase II trial of high-dose mitoxantrone, carboplatin, and cyclophosphamide with autologous bone marrow rescue for recurrent epithelial ovarian carcinoma: analysis of risk factors for clinical outcome. Gynecol Oncol (1995) 1.41
Bacteriophage and associated polysaccharide depolymerases--novel tools for study of bacterial biofilms. J Appl Microbiol (1998) 1.41
Hydroxyurea and etoposide: in vitro synergy and phase I clinical trial. J Natl Cancer Inst (1988) 1.41
Detection of thirty-second cognitive activations in single subjects with positron emission tomography: a new low-dose H2(15)O regional cerebral blood flow three-dimensional imaging technique. J Cereb Blood Flow Metab (1993) 1.41
Fluorescent lights, ultraviolet lamps, and risk of cutaneous melanoma. BMJ (1988) 1.41
The results of modified use of chemotherapy for patients with metastatic breast cancer. Eur J Cancer (1994) 1.40
Transoesophageal echocardiography during surgery for intra-atrial masses. Anaesthesia (2003) 1.40
The treatment of metastatic renal cell carcinoma patients with recombinant human gamma interferon. Cancer J Sci Am (1998) 1.40
Direct detection of 8-oxodeoxyguanosine and 8-oxoguanine by avidin and its analogues. Anal Biochem (1998) 1.40
A colleague with a drink problem. Practitioner (1989) 1.39
Laparoscopic pelvic lymph node dissection: a review of 103 consecutive cases. J Urol (1994) 1.39
Phosphoinositide-dependent activation of the ADP-ribosylation factor GTPase-activating protein ASAP1. Evidence for the pleckstrin homology domain functioning as an allosteric site. J Biol Chem (2000) 1.38
Functional analysis of human T cell subsets defined by monoclonal antibodies. III. Regulation of helper factor production by T cell subsets. J Immunol (1981) 1.38
The effects of premedication drugs on the lower oesophageal high pressure zone and reflux status of rhesus monkeys and man. Gut (1975) 1.38
Zinc abuse and sideroblastic anemia. Am J Hematol (1993) 1.38
Multivariate analysis of prognostic variables in patients with metastatic testicular cancer. Cancer Res (1983) 1.38
Heterogeneity and clinical significance of ETV1 translocations in human prostate cancer. Br J Cancer (2008) 1.37
Cardiac metastases from soft-tissue sarcomas. J Clin Oncol (1986) 1.36